Company Profile

NARAYANA HRUDAYALAYA LTD.

NSE : NHBSE : 539551ISIN CODE : INE410P01011Industry : Hospital & Healthcare ServicesHouse : Private
BSE219.500.2 (+0.09 % )
PREV CLOSE (Rs.) 219.30
OPEN PRICE (Rs.) 219.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5928
TODAY'S LOW / HIGH (Rs.)214.60 219.75
52 WK LOW / HIGH (Rs.)182 289
NSE214.55 -0.65 (-0.3 % )
PREV CLOSE(Rs.) 215.20
OPEN PRICE (Rs.) 220.50
BID PRICE (QTY) 214.55 (100 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 12957
TODAY'S LOW / HIGH(Rs.) 210.00 220.50
52 WK LOW / HIGH (Rs.)182.8 278

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 1.56
P/E Ratio 140.71
Book Value (Rs.) 56.36
Face Value (Rs.) 10
MCap (Rs. in Mn) 44857.20
Price/Earning (TTM) 37.23
Price/Sales (TTM) 2.24
Price/Book (MRQ) 3.89
PAT Margin (%) 3.16
ROCE (%) 8.72
Incorporation Year : 2000

Management Info :

Devi Prasad Shetty - Chairman Emmanuel Rupert - Managing Director

Registered Office :

Address : No.258/ A,Bommasandra Industiral Area,Anekal T Q,
Bengaluru,
Karnataka-562158

Phone : 91-080-27835000

Registrar's Details : Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
12Apr04-12-2019$Narayana Hrudayalaya incorporates wholly owned subsidiary company Narayana Hrudayalaya incorpo

Narayana Hrudayalaya has incorporated a wholly owned subsidiary -- ‘Narayana Health North America LLC’ in the State of Delaware, US on April 09, 2019 (Certificate of Formation of the LLC received by the Company on April 11, 2019). The Company was incorporated to provide consultancy services in the Healthcare sector.

The company will set up a Business Process and Technology Consultancy business in US. This Company would utilize NH's processes, protocols and technology with the aim to improve operational efficiencies to ensure a better healthcare delivery experience for all stakeholders.

Narayana Hrudayalaya is one of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities.

Narayana Hrudayalaya has incorporated a wholly owned subsidiary..
12Apr04-12-2019$Narayana Hrudayalaya gains on incorporating wholly owned subsidiary company Narayana Hrudayalaya gains o

Narayana Hrudayalaya is currently trading at Rs. 218.30, up by 1.40 points or 0.65% from its previous closing of Rs. 216.90 on the BSE.

The scrip opened at Rs. 218.00 and has touched a high and low of Rs. 218.30 and Rs. 218.00 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 289.00 on 07-May-2018 and a 52 week low of Rs. 182.00 on 30-Jan-2019.

Last one week high and low of the scrip stood at Rs. 220.45 and Rs. 212.95 respectively. The current market cap of the company is Rs. 4455.07 crore.

The promoters holding in the company stood at 63.85%, while Institutions and Non-Institutions held 28.87% and 7.28% respectively.

Narayana Hrudayalaya has incorporated a wholly owned subsidiary -- ‘Narayana Health North America LLC’ in the State of Delaware, US on April 09, 2019 (Certificate of Formation of the LLC received by the Company on April 11, 2019). The Company was incorporated to provide consultancy services in the Healthcare sector.

The company will set up a Business Process and Technology Consultancy business in US. This Company would utilize NH's processes, protocols and technology with the aim to improve operational efficiencies to ensure a better healthcare delivery experience for all stakeholders.

Narayana Hrudayalaya is one of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities.

Narayana Hrudayalaya is currently trading at Rs. 218.30, up by..
27Mar03-27-2019$Narayana Hrudayalaya to incorporate subsidiary company in US Narayana Hrudayalaya to inco

Narayana Hrudayalaya has received approval to incorporate a limited liability company (LLC) in the US which will be a 100% subsidiary of the company. The Board of Directors of the Company at its meeting held on March 25, 2019 has approved the same.

The company is actively evaluating plans to monetize its experience and expertise across healthcare facilities across the globe. The company in this regard proposes to set up a Business Process and Technology Consultancy business in US.

Narayana Hrudayalaya is one of the leading private healthcare service providers in India, operating a chain of multispecialty, tertiary and primary healthcare facilities.

Narayana Hrudayalaya has received approval to incorporate a lim..
26Mar03-26-2019$ Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Intimation Pursuant To Regu
Pursuant to the provisions of Regulations 24(1) and 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company in its meeting held on 25 March 2019, has accorded its consent to appoint Mr. Muthuraman Balasubramanian (DIN: 00004757), Independent Director of the Company on the Board of Health City Cayman Islands Limited, an unlisted material subsidiary incorporated under the laws of Cayman Islands, on or before 1st April 2019.
Pursuant to the provisions of Regulations 24(1) and 30(9) of SE..
15Mar03-15-2019$Narayana Hrudayalaya informs about investor meet Narayana Hrudayalaya informs

Narayana Hrudayalaya has informed about meetings with Institutional Investors to be held on 14th and 15th March 2019, under Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Narayana Hrudayalaya has informed about meetings with Instituti..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit159.03584.22
Gross Profit 275.3 954.14
Operating Profit 604.531942.95
Net Sales 5250.6518475.75
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dr Lal Pathlabs (BSE)
 1064.05 (1.14%)
M.Cap ( in Cr)
8867.96
Transgene Biotek (BSE)
 4.99 (4.83%)
M.Cap ( in Cr)
37.81
Indraprastha Medical (BSE)
 39.40 (0.13%)
M.Cap ( in Cr)
361.19
Aster DM Healthcare (BSE)
 152.05 (0.03%)
M.Cap ( in Cr)
7681.98
Tejnaksh Healthcare (BSE)
 50.25 (0.00%)
M.Cap ( in Cr)
51.04
Shareholding Pattern More
NON-INSTITUTION 7.28 %
PROMOTERS 63.85 %
MUTUAL FUNDS/UTI 4.01 %
FI/BANKS/INSURANCE 0.02 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested